• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Increased survival of women with luminal breast cancer and progesterone receptor immunohistochemical expression of greater than 10.

作者信息

Lehrer Steven, Rheinstein Peter H

机构信息

Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Severn Health Solutions, Severna Park, Maryland, USA.

出版信息

Cancer. 2023 Jul 1;129(13):2103-2104. doi: 10.1002/cncr.34828. Epub 2023 Apr 27.

DOI:10.1002/cncr.34828
PMID:37106560
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10450589/
Abstract
摘要

相似文献

1
Increased survival of women with luminal breast cancer and progesterone receptor immunohistochemical expression of greater than 10.管腔型乳腺癌且孕激素受体免疫组化表达大于10的女性生存率提高。
Cancer. 2023 Jul 1;129(13):2103-2104. doi: 10.1002/cncr.34828. Epub 2023 Apr 27.
2
Reply to "Increased survival of women with luminal breast cancer and progesterone receptor immunohistochemical expression of greater than 10%".对《管腔型乳腺癌且孕激素受体免疫组化表达大于10%的女性生存率提高》的回复
Cancer. 2023 Jul 1;129(13):2105. doi: 10.1002/cncr.34826. Epub 2023 Apr 27.
3
Reproductive factors and subtypes of breast cancer defined by estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2: a register-based study from Korea.由雌激素受体、孕激素受体和人表皮生长因子受体2定义的生殖因素与乳腺癌亚型：一项基于韩国登记数据的研究
Clin Breast Cancer. 2014 Dec;14(6):426-34. doi: 10.1016/j.clbc.2014.05.003. Epub 2014 Jun 23.
4
Re: Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.关于：管腔B型乳腺癌患者的Ki67指数、HER2状态及预后
J Natl Cancer Inst. 2009 Dec 16;101(24):1730; author reply 1730-1. doi: 10.1093/jnci/djp390.
5
Basal vs. luminal A breast cancer subtypes: a matched case-control study using estrogen receptor, progesterone receptor, and HER-2 as surrogate markers.基底型与腔面A型乳腺癌亚型：一项以雌激素受体、孕激素受体和HER-2作为替代标志物的配对病例对照研究。
Med Oncol. 2009;26(3):372-8. doi: 10.1007/s12032-008-9131-6. Epub 2008 Nov 26.
6
Evaluation of the Expression of Amine Oxidase Proteins in Breast Cancer.乳腺癌中胺氧化酶蛋白表达的评估。
Int J Mol Sci. 2017 Dec 20;18(12):2775. doi: 10.3390/ijms18122775.
7
Progesterone receptor expression in proliferating cancer cells of hormone-receptor-positive breast cancer.激素受体阳性乳腺癌增殖癌细胞中的孕激素受体表达
Tumour Biol. 2018 Nov;40(10):1010428318811025. doi: 10.1177/1010428318811025.
8
Receptors, associations, and risk factor differences by breast cancer subtypes: positive or negative?乳腺癌亚型的受体、关联因素及风险因素差异：阳性还是阴性？
J Natl Cancer Inst. 2011 Mar 16;103(6):451-3. doi: 10.1093/jnci/djr046. Epub 2011 Feb 23.
9
Prognostic significance of the progesterone receptor status in Ki67-high and -low Luminal B-like HER2-negative breast cancers.孕激素受体状态在Ki67高表达和低表达的腔面B样HER2阴性乳腺癌中的预后意义
Breast Cancer. 2016 Mar;23(2):310-7. doi: 10.1007/s12282-014-0575-6. Epub 2014 Nov 8.
10
Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers.以基底标志物的免疫组化表达为特征的管腔型乳腺癌的异质性
Br J Cancer. 2016 Feb 2;114(3):298-304. doi: 10.1038/bjc.2015.437. Epub 2015 Dec 17.

引用本文的文献

1
Breast cancer molecular subtype classification according to immunohistochemistry markers and its association with pathological characteristics among women attending tertiary hospitals in Tanzania.坦桑尼亚三级医院女性患者中基于免疫组化标志物的乳腺癌分子亚型分类及其与病理特征的关联
Heliyon. 2024 Sep 26;10(19):e38493. doi: 10.1016/j.heliyon.2024.e38493. eCollection 2024 Oct 15.

本文引用的文献

1
The clinical value of progesterone receptor expression in luminal breast cancer: A study of a large cohort with long-term follow-up.孕激素受体在腔面乳腺癌中的临床价值：一项大样本量且长期随访的研究。
Cancer. 2023 Apr 15;129(8):1183-1194. doi: 10.1002/cncr.34655. Epub 2023 Jan 18.
2
The Prognostic Impact of Age at Diagnosis Upon Breast Cancer of Different Immunohistochemical Subtypes: A Surveillance, Epidemiology, and End Results (SEER) Population-Based Analysis.诊断年龄对不同免疫组化亚型乳腺癌的预后影响：一项基于监测、流行病学和最终结果（SEER）人群的分析。
Front Oncol. 2020 Sep 23;10:1729. doi: 10.3389/fonc.2020.01729. eCollection 2020.
3
Research-based PAM50 signature and long-term breast cancer survival.基于研究的 PAM50 标志物与长期乳腺癌生存
Breast Cancer Res Treat. 2020 Jan;179(1):197-206. doi: 10.1007/s10549-019-05446-y. Epub 2019 Sep 21.